Metraipolis › archive › dc_e46dca0e1967
Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40962832
- DOI
- 10.1038/s41380-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T21:34:13.926Z
- SHA-256 of the archived text
cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3- Stable URL of this page
https://metraipolis.com/documento/dc_e46dca0e1967
How to cite
Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832 — Europe PMC (en), https://europepmc.org/article/MED/40962832 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e46dca0e1967 (Metraipolis archive dc_e46dca0e1967, sha256 cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3)
BibTeX
@misc{dce46dca0e1967,
title = {Dietary caffeine to assess CYP1A2 activity, tailor clozapine doses, and predict treatment response: genetic, epigenetic and clinical analyses — Europe PMC PMID:40962832},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40962832},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e46dca0e1967; sha256 cf58661b6050d4b9211638076d2eca5b7af6ddcc3c1ada6d64ff027bfbf434f3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40962832. Agents can read the archived copy with the MCP tool read_document.